DaVita HealthCare Partners Expands Beyond Dialysis in India

-- Acquires stake in India's Express Clinics, adds primary and multi-specialty care to its international health care offerings

PUNE, India, Oct. 7, 2014 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA), a leading international provider of kidney care services, today announced for the first time it will expand its international service offerings beyond kidney care with a strategic investment in India's largest independent primary care and multi-specialty chain.

Logo - http://photos.prnewswire.com/prnh/20140318/DC85712LOGO

"We're exceptionally excited to deliver primary and multi-specialty care in India, a country where we are already one of the leading dialysis providers," said Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners. "What is perhaps most exciting is the opportunity to partner with one of the top primary, multi-specialty players in that arena, Express Clinics."

DaVita HealthCare Partners will take a strategic stake in Express Clinics Pvt. Ltd., which currently operates 26 clinics located in Pune, Delhi, Mumbai and Bengaluru.

"India is a very important part of our growth plans in Asia-Pacific," said Dennis Kogod, president of DaVita HealthCare Partners' international operations. "Twenty-six primary care centers in addition to DaVita's network of 13 dialysis centers in India represent a large footprint to serve patients."

Express Clinics offers a variety of services under one roof, including consultations with general physicians and specialists, pathology and radiology, and custom health packages. The strategic partnership with DaVita HealthCare Partners will enable the company to deepen its footprint in current markets and enter new ones.

"Patient wellness begins at the primary care level," said Atul Mathur, president of DaVita HealthCare Partners in the Asia-Pacific region. "We're recognized as the leading provider of dialysis services in India and we're proud to now extend that record of clinical excellence into Indian primary and multi-specialty care services."

"We are extremely excited that this partnership provides Express Clinics the ability to leverage DaVita HealthCare Partners' expertise in creating best-in-class clinical outcomes," said Brij Sharma, founder of Express Clinics. "With the support of this partnership, we will continue to grow and deliver comprehensive, high-quality health care services to a broader patient population in India."

DaVita Kidney Care and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc.

 About DaVita HealthCare Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of dialysis services to patients with end stage renal disease. As of June 30, 2014, DaVita Kidney Care operated or provided administrative services at 2,119 outpatient dialysis centers located in the United States serving approximately 168,000 patients. The company also operated 84 outpatient dialysis centers located in 10 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, and Florida in its pursuit to deliver excellent-quality healthcare in a dignified and compassionate manner. As of June 30, 2014, HealthCare Partners provided integrated care management for nearly 829,000 managed care patients. For more information, please visit DaVitaHealthCarePartners.com.

Forward-Looking Statements
This release contains forward-looking statements within the meaning of the federal securities laws, including statements related to prospective growth, development and strategy for certain of our international operations and expected patient outcomes. Factors which could impact future results include the risks and uncertainties associated with expansion of our operations and services to markets outside the United States and starting to offer new services not previously offered in existing markets, including continuing losses, local laws and regulations, general economic and other market conditions, competition, and the risk factors set forth in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2013, and subsequent Quarterly Reports on Form 10-Q. These forward-looking statements should be considered in light of these risks and uncertainties.  We base our forward-looking statements on information currently available to us at the time of this release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of changes in underlying factors, new information, future events or otherwise

Contact Information

Media:

David Tauchen
[email protected] 
+001-(303)-876-2802